China Botanic Pharmaceutical (CBP) Reports Q3 EPS of $0.09

China Botanic Pharmaceutical (NYSE: CBP) reported Q3 EPS of $0.09, versus $0.07 reported last year. Revenue for the quarter came in at $15.08 million, versus $12.38 million reported last year.

For earnings history and earnings-related data on China Botanic Pharmaceutical (CBP) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Firm Capital Apartment REIT posts Q2 loss, plans name change
• Walmart (WMT) PT Lowered to $130 at Goldman Sachs